Skip to content
Alcyone Tx
Contact
About
Our Company
Our Team
Scientific Advisors
Board of Directors
Strategic Collaborators
Patient Advisory Committee
Science & Technology
Our Approach
Platforms
Gene Replacement
X-Reactivation
Vectorized Exon Skipping
Promoter Modulation
CMC
Falcon
ThecaFlex DR
x
™ System
Publications
Pipeline & Programs
Pipeline
ACTX-401
ACTX-101
Investors & Media
Investors
Press Releases
Careers
Contact
Investors & Media
Press
Releases
Select year:
2019
2023
2022
2021
2019
March 11, 2019
Alcyone Lifesciences Receives Breakthrough Device Designation from U.S. FDA for the ThecaFlex DRx™ System
